Search Results
204 items found for "Systemic treatment"
- G-protein-coupled receptors as therapeutic targets for glioblastoma
Treatments include surgical resection, radiotherapy, and chemotherapy. Despite this, the prognosis remains poor, with an impacted quality of life during treatment coupled with brain tumour recurrence; thus, new treatments are desperately needed.
- Adenosine receptor signalling in Alzheimer's disease
Alzheimer's disease (AD) is the most common dementia in the elderly and its increasing prevalence presents treatment Despite a better understanding of the disease, the current mainstay of treatment cannot modify pathogenesis
- Adenosine receptor signalling in Alzheimer's disease
Alzheimer's disease (AD) is the most common dementia in the elderly and its increasing prevalence presents treatment Despite a better understanding of the disease, the current mainstay of treatment cannot modify pathogenesis
- Chemical signaling regulates axon regeneration via the GPCR-Gqα pathway in Caenorhabditis elegans
Therefore, the ascaroside signaling system provides a unique example of a signaling molecule that regulates the regenerative pathway in the nervous system.
- Chemerin Forms: Their Generation and Activity
This review discusses the specific tissue expression of the components of the chemerin system, and the
- Reversible Photocontrol of Dopaminergic Transmission in Wild-Type Animals
October 2022 "Understanding the dopaminergic system is a priority in neurobiology and neuropharmacology
- Structure of the vasopressin hormone-V2 receptor-β-arrestin1 ternary complex
with the β-arrestin1 N-lobe, in agreement with structural data obtained with chimeric or synthetic systems
- Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team
focused on the development and commercialization of novel medicines for patients with central nervous system
- GPR108 is required for gambogic acid inhibiting NF-κB signaling in cancer
Herein, we identified GPR108, a GPCR protein described in innate immune system, is a potential therapeutic
- Structure of Mycobacterium tuberculosis Cya, an evolutionary ancestor of the mammalian membrane...
adenylyl cyclase (AC) Rv1625c/Cya is an evolutionary ancestor of the mammalian membrane ACs and a model system
- The complicated lives of GPCRs in cardiac fibroblasts
October 2022 "The role of different G protein-coupled receptors (GPCRs) in the cardiovascular system
- Structure of the human galanin receptor 2 bound to galanin and Gq reveals the basis of ligand...
the G-protein interface "Galanin is a neuropeptide expressed in the central and peripheral nervous systems
- G protein coupling and activation of the metabotropic GABAB heterodimer
class C G protein-coupled receptor (GPCR) heterodimer, plays a crucial role in the central nervous system
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
antibody fragments from camelids, have become indispensable tools for interrogating GPCRs both in purified systems
- N-Acyl Amides from Neisseria meningitidis and Their Role in Sphingosine Receptor Signaling
The molecular mechanisms N. meningitidis employ to manipulate the immune system, translocate the mucosal
- Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent skin...
dysbiosis and bacterial infection "Healthy skin maintains a diverse microbiome and a potent immune system
- GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for...
considered promising agents to treat Parkinson's disease, inflammation, cancer, and central nervous system
- Computational study of the conformational ensemble of CX3C chemokine receptor 1 (CX3CR1) and its...
conditions such as Alzheimer's disease and multiple sclerosis, in the recovery from central nervous system
- GRK2 in cardiovascular disease and its potential as a therapeutic target
Despite major advances in the field of pharmacological CVD treatments, particularly in the field of heart Currently-approved treatments have improved patient outcomes, but therapies to stop or reverse HF are
- Structural basis for receptor selectivity and inverse agonism in S1P5 receptors
S1P5 is predominantly expressed in nervous and immune systems, regulating the egress of natural killer
- First in Human: Early-stage COVID therapies hold promise against omicron variant
December 2021 "Early-stage studies of COVID-19 treatments from the likes of Vir Biotechnology Inc. and omicron strain of the virus was first identified in South Africa in early November, and an existing treatment
- Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR...
using live-imaging modalities, and displayed high efficiency when used to label complex 3D cellular systems
- Crinetics Pharmaceuticals announced the formation of an independently operated new company...
Radionetics aims to develop a deep pipeline of novel, targeted, nonpeptide radiopharmaceuticals for the treatment Radionetics aims to develop a deep pipeline of novel, targeted, nonpeptide radiopharmaceuticals for the treatment
- Anosmin 1 N-terminal domains modulate prokineticin receptor 2 activation by prokineticin 2
support the idea of a modulatory role of anosmin 1 in the biological effects controlled by the PK2/PKR2 system
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
This personalised approach could optimise drug efficacy while minimising adverse effects, improving treatment These insights have the potential to advance the treatment of various diseases involving GPCR signalling
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
proinflammatory glycoproteins liberated by the activation of the biochemical cascade of the complement system
- Molecular insights into psychedelic drug action
United States Food and Drug Administration's designation of psilocybin as a "Breakthrough Therapy" for treatment-resistant
- Molecular targets of psychedelic-induced plasticity
In the prospect of a psychedelic drug becoming again an approved treatment, much of these efforts have